DRG uses cookies to improve your experience on this website. Some of the cookies we use are essential for parts of the website to operate. Please be aware that if you continue without changing your cookie settings, you consent to this. For more information on our use of cookies, please review our cookie policy.

Regenerative Medicine 2017

Both gene and cell therapies do not yet have a foothold in the market but the potential for a market explosion is not only possible, but well on its way to becoming inevitable. The following infographic lays out the current state of regenerative medicine, as well as a 10-year forecast of what we can expect to see in the gene, cell, and tissue therapies market.